Trials / Terminated
TerminatedNCT01459861
Early Ambulation After Adductor Canal Block for Total Knee Arthroplasty
Assessment of Early Ambulation in Patients Receiving Continuous Adductor Canal Block With Ultrasound Guided Posterior Capsular Knee Injection vs. Femoral Nerve Block With Tibial Nerve Block Following Total Knee Replacement
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Trinity Health Of New England · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess early ambulation following total knee replacement in patients receiving continuous adductor canal block with posterior capsular injection compared to continuous femoral nerve block with tibial nerve block.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Canal Block and Capsular Injection | Continuous Adductor canal block with 15ml of ropivacaine 0.2% with epinephrine 1:400,000 followed by an infusion of ropivacaine 0.2% at 6ml per hour for 2 days post operatively. This is combined with ultrasound guided posterior capsular knee injection with 30ml ropivacaine 0.2% with epinephrine 1:400,000. |
| PROCEDURE | Femoral Nerve Block with Tibial Nerve Block | Continuous femoral nerve block with 15ml of ropivacaine 0.2% followed by an infusion of ropivacaine 0.2% at 6ml per hour for 2 days after surgery combined with tibial nerve block in the popliteal fossa with ropivacaine 0.5% up to 15ml. |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2011-10-26
- Last updated
- 2013-03-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01459861. Inclusion in this directory is not an endorsement.